Inflammation and the Vulnerable PlaqueSudden cardiac death remains the leading cause of mortality in industrialized societies, outpacing all cancer related deaths combined. The majority of sudden cardiac deaths arise from acute myocardial infarction secondary to intracoronary artery thromboses. Remarkably, the culprit lesions involved are typically not flow-limiting stenoses, 1,2 but rather inflamed lipid-laden lesions. 3,4 Whereas plaque fissuring or rupture, which exposes the intensely prothrombogenic lipid core, occurs in a majority of cases, fully 40% of intracoronary artery thromboses arise at sites of superficial erosions, where endothelial cell (EC) loss and denudation occurs. 3 The mechanisms responsible for plaque vulnerability leading to acute coronary artery thrombosis remain poorly understood. Mounting evidence, however, points toward a critical role for inflammatory processes. [5][6][7][8] Macrophages serve as the dominant cell type in the immediate site of both plaque ruptures and superficial erosions in subjects who experience acute coronary thrombosis, 8 and recent clinical investigations reveal important associations between leukocytes, 9,10 their enzymes, [11][12][13] and their activation, 14,15 in subjects with unstable angina and acute coronary syndromes. In this issue of Arteriosclerosis, Thrombosis, and Vascular Biology, Sugiyama and colleagues significantly extend our knowledge of potential pathophysiologic inflammatory processes within vulnerable atheroma. 16 Using a combination of biochemical, cellular, and immunohistologic studies, they describe unifying mechanistic links between the activity of the leukocyte enzyme myeloperoxidase (MPO) and two cardinal features of vulnerable plaque: EC loss/denudation and development of a prothrombotic phenotype.
See page 1309 Myeloperoxidase: an Inflammatory Mediator of AtherosclerosisFirst identified within human atherosclerotic plaque nearly a decade ago, 17 MPO has emerged as an important potential participant in the atherosclerotic process. MPO, a member of the heme peroxidase superfamily, generates reactive oxidants and diffusible radical species as part of its normal function in innate host defenses. 18 A unique activity of MPO is its ability to use the halide chloride as cosubstrate with hydrogen peroxide to generate chlorinating oxidants such as hypochlorous acid (HOCl), a potent antimicrobicidal agent. [18][19][20]17,21 and specific chlorinated protein 20 and lipid 22 oxidation products, are all markedly enriched within human atheroma. Leukocytes use MPO to generate oxidants capable of initiating lipid peroxidation both in model systems 23,24 and in vivo, 25 including conversion of low density lipoprotein into an atherogenic form recognized by macrophage scavenger receptors. 26 MPO may also contribute to the atherosclerotic process by promoting endothelial dysfunction, by virtue of its capacity to catalytically consume nitric oxide as a substrate in vitro 27 and in vivo, 28 resulting in formation of nitric oxidederived oxidants. 29 -31 Inde...